Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01870440 · ClinicalTrials.gov registry record · Phase 4
TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
A Phase 4 study, sponsored by Northern California Retina Vitreous Associates.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT01870440: Completed Phase 4 study, sponsored by Northern California Retina Vitreous Associates.
NCT01870440 is a Phase 4 study that has completed, run by Northern California Retina Vitreous Associates. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01870440, a Phase 4 study, has completed, sponsored by Northern California Retina Vitreous Associates.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether an intravitreal dexamethasone implant (Ozurdex, Allergan) is effective to manage macular edema secondary to non-infectious uveitis.
Interventions
- DRUG Ozurdex Intravitreal Injection (0.7 mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-02 |
| Phase | Phase 4 |
What the finished NCT01870440 record still lists
NCT01870440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Ozurdex Intravitreal Injection (0.7 mg) is the first listed.
NCT01870440 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01870440 about?
NCT01870440 is a clinical study titled "TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema". The purpose of this study is to determine whether an intravitreal dexamethasone implant (Ozurdex, Allergan) is effective to manage macular edema secondary to non-infectious uveitis.
What is the current status of trial NCT01870440?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2013-05. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01870440?
The interventions under investigation include: Ozurdex Intravitreal Injection (0.7 mg) (DRUG).
Who is sponsoring clinical trial NCT01870440?
This trial is sponsored by Northern California Retina Vitreous Associates, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01870440's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia